Looking forward to an update on the Heranova China study and potential commercial roll-out agreement. As per the below, there seems to be sooo much potential in this deal in particular.
"MEM is pleased to announce the commencement of in vitro utilisation testing of its Felix™ System in China, as part of the agreement with Heranova Lifesciences HK Limited........."
"Subject to positive results, Memphasys and Heranova will work towards an exclusive distribution agreement with the option of licensing and manufacturing the Felix TM System in the Territory, and finance of clinical trials and applications for NMPA Registration in the China."
"Results to pave the way to access China’s IVF market, valued at USD 5.37 billion in 2023, is projected to grow to USD 9.04 billion by 2030."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.917M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 8618251 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2500000 | 2 |
View Market Depth
| Last trade - 16.12pm 13/06/2025 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable